Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Protein*

The human immunodeficiency virus type 1 p6 protein represents a docking site for several cellular and viral binding factors and fulfills major roles in the formation of infectious viruses. To date, however, the structure of this 52-amino acid protein, by far the smallest lentiviral protein known, either in its mature form as free p6 or as the C-terminal part of the Pr55 Gag polyprotein has not been unraveled. We have explored the high resolution structure and folding of p6 by CD and NMR spectroscopy. Under membranous solution conditions, p6 can adopt a helix-flexible helix structure; a short helix-1 (amino acids 14–18) is connected to a pronounced helix-2 (amino acids 33–44) by a flexible hinge region. Thus, p6 can be subdivided into two distinct structural and functional domains; helix-2 perfectly defines the region that binds to the virus budding factor AIP-1/ALIX, indicating that this structure is required for interaction with the endosomal sorting complex required for transport. The PTAP motif at the N terminus, comprising the primary late assembly domain, which is crucial for interaction with another cellular budding factor, Tsg101, does not exhibit secondary structure. However, the adjacent helix-1 may play an indirect role in the specific complex formation between p6 and the binding groove in Tsg101. Moreover, binding studies by NMR demonstrate that helix-2, which also comprises the LXXLF motif required for incorporation of the human immunodeficiency virus type 1 accessory protein Vpr into budding virions, specifically interacts with the Vpr binding region, indicating that under the specific solution conditions used for structure analysis, p6 adopted a functional conformation.

[1]  Rebecca L Rich,et al.  Structure and functional interactions of the Tsg101 UEV domain , 2002, The EMBO journal.

[2]  M. Emerman HIV-1, Vpr and the cell cycle , 1996, Current Biology.

[3]  L. Ratner,et al.  Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein , 1998, Journal of Virology.

[4]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[5]  W. Paxton,et al.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.

[6]  W. Greene,et al.  Functional and Structural Characterization of Synthetic HIV-1 Vpr That Transduces Cells, Localizes to the Nucleus, and Induces G2 Cell Cycle Arrest* , 2000, The Journal of Biological Chemistry.

[7]  H. Kräusslich,et al.  Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.

[8]  W. Sundquist,et al.  Mechanisms of enveloped RNA virus budding. , 2002, Trends in cell biology.

[9]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[10]  P. Bieniasz,et al.  Role of ESCRT-I in Retroviral Budding , 2003, Journal of Virology.

[11]  E. Wingender,et al.  The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-Motif , 1994 .

[12]  R. Knoblauch,et al.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr , 1995, Journal of virology.

[13]  C. Flexner,et al.  Mutations of the Human Immunodeficiency Virus Type 1 p6Gag Domain Result in Reduced Retention of Pol Proteins during Virus Assembly , 1998, Journal of Virology.

[14]  V. Vogt Ubiquitin in retrovirus assembly: actor or bystander? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Strack,et al.  Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain , 2000, Journal of Virology.

[16]  E. Freed,et al.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease , 1995, Journal of virology.

[17]  J. Wills,et al.  Identification of Retroviral Late Domains as Determinants of Particle Size , 1999, Journal of Virology.

[18]  S. Vajda,et al.  Predicted and trifluoroethanol‐induced α‐helicity of polypeptides , 1998 .

[19]  U. Lessel,et al.  NMR spectroscopic evidence that helodermin, unlike other members of the secretin/VIP family of peptides, is substantially structured in water. , 1996, Biochemistry.

[20]  A. Hay,et al.  Structural characteristics of the M2 protein of influenza a viruses: Evidence that it forms a tetrameric channe , 1991, Virology.

[21]  F. Mammano,et al.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles , 1995, Journal of virology.

[22]  Richard Hughey,et al.  Hidden Markov models for detecting remote protein homologies , 1998, Bioinform..

[23]  Tomoshige Kino,et al.  Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. , 2004, DNA and cell biology.

[24]  Giovanni Soda,et al.  Exploiting the past and the future in protein secondary structure prediction , 1999, Bioinform..

[25]  Z. Matsuda,et al.  Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. , 1995, The Journal of general virology.

[26]  G P Nolan,et al.  Resistance is futile: assimilation of cellular machinery by HIV-1. , 2001, Immunity.

[27]  W C Johnson,et al.  Protein secondary structure and circular dichroism: A practical guide , 1990, Proteins.

[28]  V. Planelles,et al.  The role of Vpr in HIV-1 pathogenesis. , 2005, Current HIV research.

[29]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[30]  Wesley I. Sundquist,et al.  Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein , 2002, Nature Structural Biology.

[31]  E. Freed,et al.  The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner , 2002, Journal of Virology.

[32]  G. Kleywegt Use of non-crystallographic symmetry in protein structure refinement. , 1996, Acta crystallographica. Section D, Biological crystallography.

[33]  J. Sodroski,et al.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Sundquist,et al.  The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding*♦ , 2004, Journal of Biological Chemistry.

[35]  E. Freed,et al.  Viral Late Domains , 2002, Journal of Virology.

[36]  J. Luban HIV-1 and Ebola virus: The getaway driver nabbed , 2001, Nature Medicine.

[37]  B. Gay,et al.  The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the p6gag Protein of HIV-1* , 2004, Journal of Biological Chemistry.

[38]  Pierre Baldi,et al.  Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles , 2002, Proteins.

[39]  H. Kräusslich,et al.  Intracellular transport of retroviral capsid components. , 1996, Current topics in microbiology and immunology.

[40]  P. Henklein,et al.  Influenza A virus protein PB1‐F2: synthesis and characterization of the biologically active full length protein and related peptides , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[41]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[42]  Hans Robert Kalbitzer,et al.  Improved representation of two-dimensional NMR spectra by local rescaling , 1990 .

[43]  J. Garnier,et al.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. , 1978, Journal of molecular biology.

[44]  W. Sundquist,et al.  The Protein Network of HIV Budding , 2003, Cell.

[45]  P. Bieniasz,et al.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress , 2001, Nature Medicine.

[46]  É. Cohen,et al.  Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[47]  W. Greene,et al.  Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy , 2002, Nature Medicine.

[48]  E. Zuiderweg,et al.  Mapping protein-protein interactions in solution by NMR spectroscopy. , 2002, Biochemistry.

[49]  A. Calistri,et al.  AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding , 2003, Cell.

[50]  M. Buck,et al.  Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins , 1998, Quarterly Reviews of Biophysics.

[51]  L. Verplank,et al.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[53]  H. Göttlinger,et al.  Isolation of Human Immunodeficiency Virus Type 1 Cores: Retention of Vpr in the Absence of p6gag , 2000, Journal of Virology.

[54]  T. Patschinsky,et al.  The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles , 2002, Journal of Virology.

[55]  P. Henklein,et al.  Structural Characterization of the HIV-1 Vpr N Terminus , 2003, Journal of Biological Chemistry.

[56]  B. Rost,et al.  Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.

[57]  R. Gorelick,et al.  A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles , 1995, Journal of virology.

[58]  H. Göttlinger,et al.  A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr , 1996, Journal of virology.

[59]  N. Blom,et al.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. , 1999, Journal of molecular biology.

[60]  Wesley I. Sundquist,et al.  Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding , 2001, Cell.

[61]  M. Bukrinsky,et al.  Viral protein R of HIV‐1 , 1999, Reviews in medical virology.

[62]  P. Štrop,et al.  Structural and functional studies in vitro on the p6 protein from the HIV-1 gag open reading frame. , 1993, Biochimica et biophysica acta.

[63]  E. Chertova,et al.  Mutational Analysis of the Hydrophobic Tail of the Human Immunodeficiency Virus Type 1 p6Gag Protein Produces a Mutant That Fails To Package Its Envelope Protein , 1999, Journal of Virology.

[64]  Erin L Myers,et al.  Tsg101, an Inactive Homologue of Ubiquitin Ligase E2, Interacts Specifically with Human Immunodeficiency Virus Type 2 Gag Polyprotein and Results in Increased Levels of Ubiquitinated Gag , 2002, Journal of Virology.

[65]  Wesley I. Sundquist,et al.  Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag , 2001, Journal of Virology.

[66]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[67]  D. Schomburg,et al.  BRAGI: a comprehensive protein modeling program system , 1988 .